AcquisitionOther
Korsana Biosciences, Inc. acquired Cyclerion Therapeutics, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Korsana Biosciences, Inc. -> Cyclerion Therapeutics, Inc.
All-stock merger to advance neurodegenerative disease therapeutics with amyloid-beta targeting program.
Open source record (SEC) ↗